Ivermectin vs. Placebo on Time to Recovery in Patients with Mild/Moderate Covid

jamanetwork.com

2 pointsqclibre222 comments

What a joke. "This study has several limitations. First, the low mortality and hospitalization rates observed preclude drawing strict inferences on whether there are statistical difference"

The whole point is that this is a study about "mild to moderate cases". They weren't expecting deaths or hospitalizations, and that wasn't really what they were looking for.

They were looking to see if ivermectin shortened time to recovery. And it did, by a day. Which wasn't enough for it to be considered clinically relevant.

Reply on news.ycombinator.com